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ABSTRACT
Orofacial clefts are one of the most common pathologies present at birth. The 
aim of the study was to evaluate the presence of PGP 9.5, substance P, VIP, 
CGRP, myelin and NFG in cleft affected mucosa of alveolar process, soft and 
hard palate, vomer and lip.
Methods. Orofacial cleft affected mucosa tissue samples were obtained 
during surgical cleft correction from 21 children aged from 2 months to 
9 years and 10 months. Prepared tissue sections were stained by immunohis-
tochemistry for PGP 9.5, substance P, VIP, CGRP, myelin and NGF. The inten-
sity of staining was graded semiquantitatively. 
Results. Mostly moderate number and numerous PGP 9.5, substance P, 
VIP, CGRP, myelin and NGF-containing nerve fibres and nerve fibre bundles 
and CGRP and NGF positive keratinocytes were detected. The most immuno-
reactive for PGP 9.5, myelin and NGF were nerve fibres, nerve fibre bundles 
and keratinocytes in lip mucosa tissue samples. Typically, PGP 9.5-contain-
ing nerve fibres were detected in subepithelium close to basal lamina, near 
blood vessels; thin PGP 9.5 positive nerve fibres were also observed between 
keratinocytes. Immunoreactivity of CGRP was higher than of substance P in 
nerve fibres and nerve fibre bundles. Statistically significant positive correla-
tion was observed between all markers in subepithelium of all tissue samples.
Conclusions. The proved statistically significant strong inter-correlation 
and the number of general neuropeptide-containing innervation (PGP 9.5), 
sensory nerves (CGRP and substance P), and parasympathetic nerves (VIP) 
is similar in orofacial cleft affected oral mucosa to such described in scientific 
literature healthy oral mucosa, except the alveolar process covering mucosa 
where the above innervation varies.
Very strong and strong statistically significant positive correlations 
between the number of PGP 9.5, substance P, CGRP and VIP positive struc-
tures on the one hand, and NGF and myelin, on the other hand, indicate a 
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connection between quality markers and common neuropeptide-containing, 
sensory and parasympathetic innervation in cleft affected oral tissue.
The number of PGP 9.5, NGF and myelin immunoreactive neuronal 
structures in lip mucosa is higher than in the alveolar process, soft and hard 
palate and vomer mucosa, suggesting the significance of qualitative common 
innervation in this organ even in the cleft affected case.
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INTRODUCTION
Orofacial clefts are determined by a multifactorial model of inheritance in 
which the interaction of genetic and environmental risk factors results in one 
of the most common pathologies presented at birth. Depending on the popula-
tion, it affects 1 in 300–2500 children. In the European population, the preva-
lence of the pathology is 1 in 700 live births [1].
Innervation plays an essential role in the development of various orofacial 
structures during embryogenesis, and neuropeptides are involved not only 
in neuronal signalling but also in cell proliferation, migration and angiogen-
esis. Therefore, defects in innervation and distribution of neuropeptides can 
partially lead to cleft palate and lip formation [2, 3]. Moreover, only limited 
research has been done about the different most common neuronal system 
subdivision neuropeptides and quality markers.
Protein gene product 9.5 (PGP 9.5) is a member of the ubiquitin hydrolase 
family of proteins [4]. It is a highly specific pan-neuronal marker which stains 
myelinated and unmyelinated nerve fibres showing the general innervation pat-
tern of the tissue [5, 6]. It is also a marker for neuroendocrine cells [7]. Previous 
research has revealed that the increase of PGP 9.5 immunoreactive nerve fibres 
in lamina propria might be associated with different oral pathologies. So, in 
oral lichen planus affected oral mucosa, an increased number of PGP 9.5-con-
taining nerve fibres near lamina propria has been found, suggesting the neuro-
inflammatory process [6]. Not only the increased number of PGP 9.5-contain-
ing, but also substance P and CGRP positive nerve fibres have been detected in 
palatal mucosa of sleep apnoics, which signalise neurogenic lesion [8].
Substance P is an 11 amino acids-containing neuropeptide, which provides 
nociception and pain signalling. Therefore, it indicates sensory innervation [9, 
10]. Substance P is synthesized by neurons and also by inflammatory cells [11], 
and it performs its function via the neurokinin 1 receptor [9]. Substance P was 
found to be strongly expressed in oral squamous cell carcinoma, confirming 
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that increase in the levels of substance P can reduce apoptosis and lead to cell 
proliferation [12].
Vasoactive intestinal peptide (VIP) is a 28-amino acid parasympathetic 
neurotransmitter. Beside neurons, it is also produced by immune cells [13]. 
It functions through the specific G-protein-coupled receptors VPAC1 and 
VPAC2, and shows the potent growth related actions that influence cell divi-
sion and neuronal survival [14, 15].
Calcitonin gene related peptide (CGRP) is a 37 amino acid neuropeptide, 
which is expressed in sensory neurons, providing nociceptive transmission in 
both central and peripheral nervous systems and giving the opportunity to 
evaluate the sensory innervation of the tissue. It is frequently co-expressed with 
substance P. CGRP is also involved in maintenance of vascular homeostasis. 
Two types of CGRP receptors – CGRP1 and CGRP2 – have been described 
[16, 17], and CGRP has been found to participate in regenerative processes by 
increasing fibroblast motility and extracellular matrix synthesis [18]. 
Nerve growth factor (NGF) is neurotrophin, which consists of 118 amino 
acids; it is produced by immune and nerve cells, keratinocytes, melanocytes, 
smooth muscle cells, fibroblasts and Schwann cells [19]. NGF plays an impor-
tant role in survival, growth and maintenance of neurons in the mammalian 
nervous system, performing functions through two different receptors, TrkA 
and p75 [20, 21]. NGF has been found to play a role in oral epithelial wound 
healing by participating in tissue remodelation, cellular proliferation, restitu-
tion, up-regulation of anti-apoptotic proteins and inflammation [22].
Myelin is a multilayered membrane ensheathing axons; therefore, it gives 
the opportunity to detect myelinated nerve fibres [23]. However, there is prac-
tically no research about the distribution of these fibres in cleft affected tissue.
On the basis of the above mentioned, the aim of this study was to evaluate 
the appearance and distribution of PGP 9.5, substance P, VIP, CGRP, myelin 
and NFG positive neuronal structures in cleft affected mucosa of alveolar pro-
cess, soft and hard palate, vomer and lip.
MATERIALS AND METHODS
Mucosa tissue samples from lip (7), alveolar process (7), vomer (1), soft palate 
(3), hard palate (2) and from the border between soft and hard palate (1) were 
obtained during surgical cleft correction in the Cleft Lip and Palate Centre at 
the Institute of Stomatology of Riga Stradiņš University from 21 children with 
nonsyndromic orofacial clefts. Tissue samples were taken from children aged 
from 2 months to 9 years and 10 months (14 boys and 7 girls). Seven children 
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had bilateral orofacial cleft, while 14 were diagnosed with unilateral orofacial 
cleft (Table 1).
Table 1. Diagnosis, sex and age of the patients.
Patient Sex Age Diagnosis Tissue
1 Boy 9 years 10 months Cheilognathouranoschisis bilateralis
Alveolar 
process mucosa
2 Boy 9 years 3 months Cheilognathouranoschisis bilateralis
3 Boy 8 years 11 months Cheilognathouranoschisis bilateralis
4 Boy 8 years 5 months Cheilognathouranoschisis bilateralis
5 Girl 9 years Cheilognathouranoschisis bilateralis
6 Boy 8 years 5 months Cheilognathouranoschisis sinistra
7 Girl 8 years 5 months Cheilognathouranoschisis sinistra
8 Boy 3 years 7 months Cheilognathouranoschisis sinistra
Hard palate 
mucosa9 Girl 3 years Cheilognathouranoschisis 
dextra
10 Boy 9 months Cheilognathouranoschisis bilateralis
Soft palate 
mucosa
11 Boy 10 months Cheilognathouranoschisis 
sinistra
12 Girl 8 months Cheilognathouranoschisis
 sinistra
13 Girl 9 months Cheilognathouranoschisis sinistra Mucosa 
from border 
between soft 
and hard palate
14 Boy 9 months Cheilognathouranoschisis 
dextra Vomer mucosa
15 Boy 2 months Cheilognathouranoschisis bilateralis
Lip mucosa
16 Boy 5 months Cheilognathouranoschisis sinistra
17 Boy 4 months Cheilognathouranoschisis sinistra
18 Boy 4 months Cheilognathouranoschisis sinistra
19 Girl 6 months Cheilognathouranoschisis sinistra
20 Girl 4 months Cheilognathouranoschisis sinistra
21 Boy 3 months Cheilognathouranoschisis 
dextra
The study was performed in accordance with the 1964 Declaration of  Helsinki. 
After written informed consent from the parents of all the 21 patients was 
received, tissue samples were obtained intraoperatively. The study was 
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approved by the Ethics Committee at Riga Stradiņš University (22.05.2003; 
17.01.2013; 5/25.06.2018). 
Alveolar process, soft and hard palate, vomer and lip mucosa tissue 
 samples were fixed in Stefanini’s solution [24]. The solution was made of 20 g 
para formaldehyde, 150 ml of picric acid, 425 ml of Shorensen`s phosphate 
buffer (pH 7.2) and 425 ml of distilled water. Further, all tissue samples were 
 dehydrated and embedded in paraffin.
PGP 9.5 (Lot number 439273A, obtained from rabbit, dilution 1:100, 
 Invitrogen, USA), substance P (code sc-58591, obtained from mouse, dilution 
1:100, Santa Cruz, USA), VIP (code sc-20727, obtained from rabbit, dilution 
1:100, Santa Cruz, USA), CGRP (catalogue number 2030101401, lot number 
281328, obtained from rabbit, dilution 1:100, Quartett Immuno-diagnostika, 
Germany), NGF (code ab6199, obtained from mouse, dilution 1:100, Abcam, 
UK), myelin (code 2233MME, obtained from mouse, dilution 1:20, Euro 
Diagnostica, Sweden) primary antibodies were used by biotin-streptavidin 
immunohistochemistry (IMH) [25]. Tissue samples were counterstained with 
 haematoxylin to stain the nuclei blue. All antibodies we used in this study were 
tested for positive and negative control.
The intensity of immunostaining was graded semiquantitatively. Respec-
tively, no positive structures in the visual field were labeled as 0; occasional 
positive structures in the visual field were labeled with 0/+; few positive struc-
tures in the visual field were labeled with +; few to moderate number of posi-
tive structures in the visual field were labeled with +/++; moderate number of 
positive structures in the visual field were labeled with ++; moderate to numer-
ous positive structures in the visual field were labeled with ++/+++; numer-
ous positive structures in the visual field were labeled with +++; numerous to 
abundant positive structures in the visual field were labeled with +++/++++; 
and abundance of positive structures in the visual field were labeled with ++++ 
[26]. 
The data processing was performed with SPSS software, version 22.0 (IBM 
Company, Chicago, IL, USA). Spearman’s rank correlation coefficient was used, 
where r = 0–0.2 was assumed as a very weak correlation, r = 0.2–0.4 – a weak 
correlation, r = 0.4–0.6 – a moderate correlation, r = 0.6–0.8 – a strong corre-
lation and r = 0.8–1.0 – a very strong correlation. The level of significance for 
the test was chosen as 5% (p-value < 0.05).
For visual illustration, Leica DC 300F digital camera was used. Image pro-
cessing and analysis was performed by Image Pro Plus 6.0 software (Media 
Cybernetics, Silver Spring, Maryland, USA).
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RESULTS
PGP 9.5-containing nerve fibre bundles and nerve fibres typically were 
observed around blood vessels (Figure 1) and in lamina propria close to epithe-
lium (Figure 2), also some thin nerve fibres were found between keratinocytes. 
Mainly, few to moderate number (+/++) of PGP 9.5-containing nerve fibres 
were detected in mucosa of alveolar process. Few (+) to abundant (++++) but 
mostly moderate number (++) of PGP 9.5-containing nerve fibres and nerve 
fibre bundles were found in mucosa of soft and hard palate and vomer. Mainly 
moderate to numerous (++/+++) PGP 9.5 positive neuronal structures were 
observed in cleft affected lip mucosa tissue samples.
Commonly, a moderate number (++) of substance P-containing nerve fibre 
bundles and nerve fibres were detected in lamina propria, also innervating 
sebaceous glands and near blood vessels (Figure 3). Few to moderate  number 
(+/++) of substance P positive nerve fibres were observed in subepithelial 
 tissue of alveolar process mucosa. Mainly a moderate number (++) of sub-
stance P immunoreactive neuronal structures was also found in soft and hard 
palate, vomer and lip mucosa tissue samples.
Commonly, VIP-containing nerve fibres and nerve fibre bundles were 
detected in the subepithelium (Figure 4) and in the wall of blood vessels 
 (Figure 5). Few to moderate number (+/++) of VIP immunoreactive nerve 
fibres were seen in lamina propria of alveolar process mucosa, while the sub-
epithelium of soft and hard palate and vomer demonstrated mainly a moderate 
number (++) of VIP positive neuronal structures. Mainly numerous (+++) 
VIP-containing nerve fibres and nerve fibre bundles were observed in the sub-
epithelium of lip.
Also, CGRP-containing nerve fibre bundles and separate nerve fibres were 
found in the subepithelium (Figure 6) and around the blood vessels. Moderate 
to numerous (++/+++) CGRP positive nerve fibres and nerve fibre bundles 
were detected in lamina propria of soft and hard palate, vomer and alveolar 
process. The immunoreactivity for CGRP was detected in neuroendocrine cells 
of epithelium in alveolar process and lip mucosa. However, numerous (+++) 
CGRP-containing nerve fibre bundles and nerve fibres were primarily seen in 
the subepithelium of lip; in soft and hard palate and vomer epithelium mostly 
a moderate number (++) of CGRP positive cells were detected.
NGF-containing neuronal structures were displayed in the subepithelium 
(Figure 7), and NGF positive neuroendocrine cells appeared in the epi thelium, 
typically located in the basal cell layer. Alveolar mucosa samples pri marily 
contained few to moderate number (+/++) of NGF positive nerve fibres and 
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a moderate number (++) of NGF immunoreactive cells in the epithelium. 
A moderate number (++) of NGF-containing nerve fibres, nerve fibre bundles 
and neuroendocrine cells was also detected in soft and hard palate and vomer 
tissue samples, while mostly numerous (+++) factor-containing neuronal 
structures were seen in lip mucosa.
A moderate number (++) of myelin ensheathed nerve fibres and nerve fibre 
bundles (Figure 8) occupied primarily the subepithelium of alveolar process, 
soft and hard palate and vomer mucosa. Numerous (+++) myelin-containing 
nerve fibres and nerve fibre bundles were found mostly in the subepithelial 
tissue of lip mucosa.
Figure 1. Numerous PGP 9.5-containing 
nerve fibres around a blood vessel in sub-
epithelium of alveolar process mucosa in 9 
years and 3 months old boy with bilateral 
orofacial cleft. PGP 9.5 IMH, x250.
Figure 2. Moderate number of PGP 9.5 posi-
tive nerve fibres located close to basal lamina 
and nerve fibre bundles in subepithelium of 
lip mucosa in a 5-month-old boy with uni-
lateral orofacial cleft. PGP 9.5 IMH, ×200.
Figure 3. Moderate to numerous substance 
P-containing nerve fibres in lamina propria 
and nearby blood vessels in lip tissue sam-
ples of a 4-month-old boy with unilateral 
orofacial cleft. Substance P IMH, ×100.
Figure 4. Moderate number of VIP-containing 
nerve fibres (located close to basal lamina) in 
the subepithelium on the border between 
soft and hard palate mucosa of a 9-month-
old girl with unilateral orofacial cleft. VIP IMH, 
×200.
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Figure 5. Numerous VIP-containing nerve fi-
bres in the wall of blood vessels in the sube-
pithelium of lip mucosa in a 4-month-old girl 
with unilateral orofacial cleft. VIP IMH, ×250..
Figure 6. Moderate number of CGRP positive 
nerve fibres in the subepithelium of hard pal-
ate mucosa of a 3-year-old girl with unilateral 
orofacial cleft. CGRP IMH, ×400.
Figure 7. Moderate number of NGF-contain-
ing nerve fibres seen in the subepithelium 
on the border between soft and hard palate 
mucosa of a 9-month-old girl with unilateral 
orofacial cleft. NGF IMH, ×200.
Figure 8. Numerous myelin positive nerve 
fibres in the subepithelium of lip mucosa in 
a 6-month-old girl with unilateral orofacial 
cleft. Myelin IMH, ×100.
Statistically significant positive correlations were found between the numbers 
of all the studied markers in the neuronal structures of subepithelial tissue 
(Table 2). Very strong statistically significant positive correlation was observed 
between the number of myelin and PGP 9.5, NGF and substance P, NGF and 
myelin. Strong statistically significant positive correlation was observed 
between NGF and PGP 9.5, NGF and CGRP, myelin and substance P, myelin 
and VIP, myelin and CGRP, substance P and CGRP, VIP and CGRP, substance 
P and VIP, PGP 9.5 and substance P. Moderate statistically significant cor-
relation was detected between NGF and VIP, CGRP and PGP 9.5, VIP and 
PGP 9.5.
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Table 2. Spearman’s rank correlations between PGP 9.5, substance P, VIP, CGRP, myelin and 
NGF.
PGP 9.5 Substance P VIP CGRP Myelin
NGF R=0.789, P=0.00002
R=0.828,
P=0
R=0.595, 
P=0.00445
R=0.710, 
P=0.00031
R=0.907,  
P=0
Myelin R=0.804, P=0.00001
R=0.757, 
P=0.00007
R=0.653, 
P=0.00135
R=0.718, 
P=0.00025
CGRP R=0.460, P=0.03580
R=0.689, 
P=0.00056
R=0.623, 
P=0.00254
VIP R=0.599, P=0.00415
R=0.724, 
P=0.00021
Substance P R=0.764, P=0.00006
DISCUSSION
Orofacial clefts cause a range of functional and cosmetic problems [27]. 70% 
of all orofacial clefts are nonsyndromic clefts, which have complex aetiology 
with multiple genetic and environmental factors [28]. The pathogenesis of oro-
facial cleft development and the role of innervation of oral mucosa in it still is 
incompletely understood.
Very strong and strong statistically significant positive correlation between 
the studied markers – PGP 9.5, myelin, NGF, substance P, CGRP and VIP – 
indicates a connection between quality markers and neuropeptides. There are 
no previous studies which show a correlation between expression of neuropep-
tides and quality markers in neuronal structures, making this study innovative 
and unique. Additionally, a strong statistically significant positive correlation 
was detected between all neuropeptides – CGRP and substance P, CGRP and 
VIP, substance P and VIP –, giving evidence of the distribution pattern of these 
sensory and parasympathetic neuropeptides in the cleft affected tissue. Coex-
istence of CGRP and substance P has been seen in nerve fibres in oral lichen 
planus affected mucosa and in nerve fibres innervating the palates of sleep 
apnoics and habitual snorers; therefore, our results have partially been proved 
by the data of other authors [6, 8].
Mainly moderate to numerous PGP 9.5 immunoreactive nerves were local-
ized in our patients’ lip tissue and in the boundary area of soft and hard palate; 
however, only few to moderate number of neuronal structures were seen in 
alveolar process mucosa. This corresponds to a study where PGP 9.5 posi-
tive nerve fibres were detected forming a dense network in lamina propria of 
Very strong statistically 
significant positive correlation
Strong statistically significant 
positive correlation
Moderate statistically significant 
positive correlation
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healthy human lip and alveolar process mucosa [29]. Also, a rich supply of PGP 
9.5-containing nerve fibres has been found in the boundary area of soft and 
hard palate in healthy rat oral mucosa [30]. Like in our study, PGP 9.5-con-
taining nerve fibres have been detected in the wall of blood vessels in healthy 
human palate [29]. Therefore, it can be suggested that this is typical of oral 
mucosa, except the alveolar process, where the number of PGP 9.5-containing 
neuronal structures can vary.
Only few to moderate number of NGF-containing nerve fibres, nerve fibre 
bundles and neuroendocrine cells were observed in our patients’ palate and 
alveolar process mucosa. NGF has been found to play a role in processes which 
are important in orofacial development – cell survival, cellular proliferation, 
restitution, up-regulation of anti-apoptotic proteins and remodellation [22]. 
Therefore, it can be suggested that the detected number of NGF-containing 
neuronal structures in our patients’ mucosa could possibly be not enough to 
provide for the previously mentioned processes and partially play a role in cleft 
development.
Moderate to numerous CGRP positive neuronal structures were detected in 
lamina propria of soft and hard palate, vomer, alveolar process and lip mucosa. 
According to another study, numerous CGRP positive nerve fibres have also 
been found in the hard palate of a healthy rat [31]. Like in our study, healthy 
soft and hard palate mucosa of rat, cat and monkey showed CGRP immuno-
reactive neuronal structures in subepithelium and around blood vessels [32]. 
Therefore, we can suggest that the obtained number and localization of CGRP-
containing nerve fibres might be typical of oral mucosa. Soft and hard pal-
ate mucosa contained mainly moderate to numerous CGRP positive neuronal 
structures, while a moderate number of substance P-containing nerve fibres 
were observed in this localization. In another study, the boundary area of soft 
and hard palate of a healthy rat also demonstrated a higher number of CGRP-
containing nerve fibres than substance P-containing nerves [30]. Based on the 
above mentioned, we conclude that the described substance P and CGRP neu-
ronal distribution pattern can be assumed to be typical of palate mucosa.
Few to moderate number of substance P-containing nerve fibres were found 
in our patients’ mucosa, while another studies showed numerous substance P 
positive neuronal structures in the hard palate and alveolar process of a healthy 
rat [31, 33]. Like in our study, substance P-containing nerve fibres have been 
detected near blood vessels in healthy human alveolar process mucosa [34]. 
Substance P was found to be strongly expressed in oral squamous cell car-
cinoma, assuming that an increase in the levels of substance P can reduce 
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 apoptosis and lead to cell proliferation [12]. Thus, we suggest that sensory 
nerves in cleft palate partially do not influence the cell proliferation and the 
programmed cell death in our patients. 
Only few to moderate number of VIP positive neuronal structures were 
observed in alveolar process mucosa; a moderate number of nerves was found 
in the soft and hard palate and vomer mucosa of our patients. However, numer-
ous VIP immunoreactive nerve fibres have been found in healthy human soft 
palate mucosa [35]. Similarly to our findings, VIP positive nerve fibres have 
been found in the wall of blood vessels in healthy human mucosa and in the 
subepithelium of healthy rat hard palate [31, 35]. VIP is thought to have potent 
growth-related actions that influence cell division and neuronal survival [15]. 
It can be suggested that distribution of these parasympathetic nerve fibres par-
tially does not make an impact on the action of VIP in cleft affected tissue.
A moderate number of myelin ensheathed neuronal structures was seen in 
alveolar process, soft and hard palate and vomer mucosa, while mostly numer-
ous neuronal structures were found in lip mucosa. Commonly, this suggests 
the presence of myelinated nerves in cleft affected tissue without any specific 
changes in the quality of nerves. There is practically no previous research about 
the distribution of myelinated nerve fibres in orofacial cleft affected mucosa. 
Moreover, decreased number and degeneration of myelinated nerve fibres have 
been associated with other different oral pathologies. Compared to controls, 
the number of myelinated nerve fibres was found to be decreased in gingival 
mucosa of streptozocin-diabetic mice [36], while myelinated nerves showed 
degenerative changes in mucosa of obstructive sleep apnoea patients [37]. 
Therefore, it can be suggested, that cleft affected mucosa does not show just 
previously described properties of myelinated fibres degeneration.
CONCLUSIONS
The proved statistically significant strong inter-correlation and the number 
of general neuropeptide-containing innervation (PGP 9.5), sensory nerves 
(CGRP and substance P), and parasympathetic nerves (VIP) is similar in oro-
facial cleft affected oral mucosa to such of healthy oral mucosa described in 
scientific literature, except the alveolar process covering mucosa where the 
above innervation varies.
Very strong and strong statistically significant positive correlations between 
the number of PGP 9.5, substance P, CGRP and VIP positive structures on the 
one hand, and NGF and myelin, on the other hand, indicate the connection 
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between the quality markers and common neuropeptide-containing, sensory 
and parasympathetic innervation in cleft affected oral tissue.
The number of PGP 9.5, NGF and myelin immunoreactive neuronal struc-
tures in lip mucosa is higher than in the alveolar process, soft and hard palate 
and vomer mucosa suggesting the significance of qualitative common innerva-
tion in this organ even in the cleft affected case.
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